Cytokine Release Syndrome and Immune Effector Cell–Associated Neurotoxicity Syndrome Following Axicabtagene Ciloleucel or Brexucabtagene Autoleucel Chimeric Antigen Receptor T-Cell Therapy: Center for International Blood and Marrow Transplant Research Data
- DOI
- 10.1016/j.jtct.2026.07.029
- Published
- 2026-07
- Container
- Transplantation and Cellular Therapy
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.jtct.2026.07.029,
title = {Cytokine Release Syndrome and Immune Effector Cell–Associated Neurotoxicity Syndrome Following Axicabtagene Ciloleucel or Brexucabtagene Autoleucel Chimeric Antigen Receptor T-Cell Therapy: Center for International Blood and Marrow Transplant Research Data},
author = {Matthew J. Frigault and Richard T. Maziarz and Theresa Amoloja and Lea Burke and Valkal Bhatt and Amy Moskop and Marcelo Pasquini and John F. DiPersio},
year = {2026},
journal = {Transplantation and Cellular Therapy},
doi = {10.1016/j.jtct.2026.07.029},
url = {https://doi.org/10.1016/j.jtct.2026.07.029}
}RIS
TY - JOUR TI - Cytokine Release Syndrome and Immune Effector Cell–Associated Neurotoxicity Syndrome Following Axicabtagene Ciloleucel or Brexucabtagene Autoleucel Chimeric Antigen Receptor T-Cell Therapy: Center for International Blood and Marrow Transplant Research Data AU - Matthew J. Frigault AU - Richard T. Maziarz AU - Theresa Amoloja AU - Lea Burke AU - Valkal Bhatt AU - Amy Moskop AU - Marcelo Pasquini AU - John F. DiPersio PY - 2026 JO - Transplantation and Cellular Therapy DO - 10.1016/j.jtct.2026.07.029 UR - https://doi.org/10.1016/j.jtct.2026.07.029 ER -
APA
Frigault, M. J., Maziarz, R. T., Amoloja, T., Burke, L., Bhatt, V., Moskop, A., Pasquini, M., & DiPersio, J. F. (2026). Cytokine Release Syndrome and Immune Effector Cell–Associated Neurotoxicity Syndrome Following Axicabtagene Ciloleucel or Brexucabtagene Autoleucel Chimeric Antigen Receptor T-Cell Therapy: Center for International Blood and Marrow Transplant Research Data. Transplantation and Cellular Therapy. https://doi.org/10.1016/j.jtct.2026.07.029
Source records
- crossref · retrieved 2026-09-26T01:50:14.509Z